Page 41 - 《中国药房》2024年5期
P. 41
in Melicope pteleifolia[J]. Chin Tradit Herb Drugs,2016, [15] 刘静,朱琰,范佳伟. 及早中医药健脾治疗对大肠癌术后
47(22):4103-4110. 患者生存质量影响[J]. 辽宁中医药大学学报,2021,23
[ 7 ] 程艳薇,南惠玲,林青华,等.民族药三叉苦化学成分、药 (9):6-9.
理作用研究进展及质量标志物(Q-Marker)预测分析[J]. LIU J,ZHU Y,FAN J W. Impact of quality of life in post-
药学研究,2023,42(8):605-614,626. operation colorectal cancer patients receiving early treat‐
CHENG Y W,NAN H L,LIN Q H,et al.Research pro‐ ment of tonifying spleen by traditional Chinese medicine
gressi on the chemical constituents,pharmacological, [J]. J Liaoning Univ Tradit Chin Med,2021,23(9):6-9.
effects and the prediction and analysis of Q-Marker of [16] YEH D W,HUANG L R,CHEN Y W,et al. Interplay
Melicope pteleifolia[J]. Pharm Res,2023,42(8):605- between inflammation and stemness in cancer cells:the
614,626. role of Toll-like receptor signaling[J]. J Immunol Res,
[ 8 ] YAO Q,GAO Y,LAI C C,et al. The phytochemistry, 2016,2016:4368101.
pharmacology and applications of Melicope pteleifolia:a [17] HOLLDACK J. Toll-like receptors as therapeutic targets
review[J]. J Ethnopharmacol,2020,251:112546. for cancer[J]. Drug Discov Today,2014,19(4):379-382.
[ 9 ] WU T,WANG G,CHEN W,et al.Co-inhibition of BET [18] ZHU G W,HUANG Q,HUANG Y J,et al. Lipopolysac‐
proteins and NF-κB as a potential therapy for colorectal charide increases the release of VEGF-C that enhances
cancer through synergistic inhibiting MYC and FOXMl cell motility and promotes lymphangiogenesis and lym‐
expressions[J].Cell Death Dis,2018,9(3):315. phatic metastasis through the TLR4-NF-κB/JNK pathways
[10] 高英,师冰,颜宏,等. 三丫苦茎总提取物及分段样品抗 in colorectal cancer[J]. Oncotarget,2016,7(45):73711-
菌活性研究[J]. 云南中医学院学报,2017,40(3):28-32. 73724.
GAO Y,SHI B,YAN H,et al. Antibacterial properties of [19] GAO X J,XU F M,ZHANG H T,et al. PKCα -GSK-
total extract and ethanol segments from stem of Evodia 3β-NF-κB signaling pathway and the possible involvement
lepta(Spreng.)Merr. against common pathogenic bacteria of TRIM21 in TRAIL-induced apoptosis[J]. Biochem Cell
[J]. J Yunnan Univ Tradit Chin Med,2017,40(3):28-32. Biol,2016,94(3):256-264.
[11] 罗桂花,林翠清,肖鸬华,等. 响应面法优化三叉苦黄酮 [20] 聂雪丽,聂春杰,买晓颖,等. EB病毒感染对结直肠癌患
提取工艺及抗氧化活性分析[J]. 食品与药品,2022,24 者癌组织TLR4/MyD88信号通路影响[J].中华医院感染
(1):1-6. 学杂志,2021,31(23):3600-3603.
LUO G H,LIN C Q,XIAO L H,et al. Optimization of ex‐ NIE X L,NIE C J,MAI X Y,et al. Effects of Epstein-
traction process of total flavonoids from Melicope pteleifolia Barr virus infection on TLR4/MyD88 signaling pathway
and evaluation of its antioxidant activity[J]. Food Drug, in cancer tissues of patients with colorectal cancer[J].Chin
2022,24(1):1-6. J Nosocomiol,2021,31(23):3600-3603.
[12] 吕长玲,杜华钰,周杰,等. 美洲大蠊多肽PAP-2对Balb/c [21] 罗梦花,陈佩文,陈志红,等. 半边旗二萜化合物5F对人
小鼠肝癌原位移植瘤免疫微环境的影响[J]. 中国临床药 结直肠癌细胞增殖、凋亡和自噬的影响[J]. 中南药学,
理学杂志,2023,39(7):994-998. 2023,9(2):407-413.
LYU C L,DU H Y,ZHOU J,et al. Effect of Periplaneta LUO M H,CHEN P W,CHEN Z H,et al. Effect of 5F on
Americana polypeptide PAP-2 on the immune microenviron- the proliferation,apoptosis and autophagy of colorectal
ment of Balb/c mice with hepatocellular carcinoma in situ cancer cells[J]. Cent South Pharm,2023,9(2):407-413.
transplanted tumors[J]. Chin J Clin Pharmacol,2023,39 [22] 何亚琴,苏进达,赵少辉,等. 结直肠癌细胞中NF-κB活
(7):994-998. 化与 TRAF6、CCR5 及 PTEN/PI3K 通路的关系及作用
[13] 孔宪斌,杨振弢,彭莹莹,等. 基于“虚、毒、瘀” 浅谈结直 [J]. 中国普通外科杂志,2022,8(10):1363-1372.
肠癌的病机和治疗[J]. 环球中医药,2020,13(12):2081- HE Y Q,SU J D,ZHAO S H,et al. Association of NF-κB
2084. activation with TRAF6,CCR5 and PTEN/PI3K pathway
KONG X B,YANG Z T,PENG Y Y,et al. Discussion on and its role in colorectal cancer cells[J]. China J Gen
the pathogenesis and treatment of colorectal cancer based Surg,2022,8(10):1363-1372.
on “deficiency,toxicity and blood stasis” [J]. Glob Tradit [23] 王娜. IRAK1激酶在结肠癌中作为西妥昔单抗协同作用
Chin Med,2020,13(12):2081-2084. 靶标机制的研究[D]. 西安:第四军医大学,2017.
[14] 荣红国,于蔚洁,杜美皎,等. 我国循证中医药领域研究 WANG N. Mechanism of IRAK1 kinase as a synergistic
热点与前沿分析[J]. 中国药房,2022,33(15):1876-1880. target of cetuximab in colon cancer[D].Xi’an:The Fourth
RONG H G,YU W J,DU M J,et al. Analysis on research Military Medical University,2017.
hotspots and frontier in domestic evidence-based tradi‐ (收稿日期:2023-09-24 修回日期:2024-02-03)
tional Chinese medicine[J]. China Pharm,2022,33(15): (编辑:唐晓莲)
1876-1880.
中国药房 2024年第35卷第5期 China Pharmacy 2024 Vol. 35 No. 5 · 547 ·